Vaxxinity, Inc. (VAXX) Financials
VAXX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 57.5 million | 33.8 million |
2023-06-30 | 71.4 million | 36.4 million |
2023-03-31 | 85.5 million | 39.4 million |
2022-12-31 | 106.4 million | 44.2 million |
VAXX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -13.3 million | 1.8 million |
2023-06-30 | -12.2 million | 2.4 million |
2023-03-31 | -20.2 million | 2.2 million |
2022-12-31 | -14.8 million | 2.4 million |
VAXX Net Income
No data available :(
VAXX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 42.5 million | - | - |
2023-06-30 | 55.8 million | - | - |
2023-03-31 | 67.6 million | - | - |
2022-12-31 | 86.8 million | 9.9 million | - |
VAXX Shares Outstanding
VAXX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 127000 | 7.9 million | 5.5 million | - |
2023-06-30 | 90000 | 8.3 million | 6.1 million | - |
2023-03-31 | 172000 | 11.4 million | 7.4 million | - |
2022-12-31 | 292000 | 13.0 million | 7.8 million | - |
VAXX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 666000 |
2023-06-30 | - | 512000 |
2023-03-31 | - | 600000 |
2022-12-31 | - | 540000 |
VAXX
Price: $0.12
52 week price:
Earnings Per Share: -0.45 USD
P/E Ratio: -1.34
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 380403
Market Capitalization: 61.8 million